NFE2L2 and cancer: p53 and Nrf2 can be a potential therapeutic target for various diseases including cancer, neurodegenerative diseases, inflammatory disorders, and potential biomarkers for cancer diagnosis, prognosis, and treatment, and help to develop new diagnostic and therapeutic strategies (117-119).